Skip to main content
Log in

Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Summary

The effect of phenobarbital treatment on bilirubin metabolism and bile secretion was studied in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis. Following cholecystectomy and choledochostomy, a balloon inflatable T tube was inserted to facilitate bile collection. Hepatic UDP-glucuronyltransferase in surgically obtained liver tissue was 25% of normal activity and bilirubin monoconjugates accounted for >80% of the pigments in bile. Phenobarbital therapy decreased the concentration of fasting serum bile acids by 33% and partially reestablished their enterohepatic cycling postprandially. The total fasting serum bilirubin concentration (>90% unconjugated) increased 21% during phenobarbital treatment and was unaffected by caloric intake. Bile flow was increased 2.7 times after phenobarbital treatment. The biliary concentration of total bilirubin was increased 2.4 times, primarily due to monoconjugated bilirubin, which accounted for 91% of the biliary pigments. Bile acid, phospholipid, cholesterol, and calcium concentrations in bile were significantly increased after phenobarbital. The data indicate that even in the presence of cholestasis an underlying deficiency in bilirubin conjugation may be confirmed by biliary pigment analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arias IM, Gartner LM, Cohen M, Ezzer JB, Levi AJ, et al: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Am J Med 47:395–409, 1969

    Google Scholar 

  2. Berthelot P, Dhumeaux D: New insights into the classification and mechanism of hereditary, chronic, nonhaemolytic hyperbilirubinemia. Gut 19:474–480, 1978

    Google Scholar 

  3. Gordon ER, Shaffer EA, Sass-Kortsak A: Bilirubin secretion and conjugation in the Crigler-Najjar syndrome type II. Gastroenterology 70:761–765, 1976

    Google Scholar 

  4. Gollan JL, Huang SN, Billing B, Sherlock S: Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Gastroenterology 68:1543–1555, 1975

    Google Scholar 

  5. Capron JP, Erlinger S: Barbiturates and biliary function. Digestion 12:43–56, 1975

    Google Scholar 

  6. Stiehl A, Thaler MM, Admirand WH: The effects of phenobarbital on bile salts and bilirubin in patients with intrahepatic and extrahepatic cholestasis. N Engl J Med 286:858–861, 1972

    Google Scholar 

  7. Bloomer JR, Boyer JL: Phenobarbital effects in cholestatic liver disease. Ann Intern Med 82:310–317, 1975

    Google Scholar 

  8. Sharp HL, Mirkin BL: Effect of phenobarbital in hyperbilirubinemia, bile acid metabolism, and microsomal enzyme activity in chronic intrahepatic cholestasis of childhood. J Pediatr 81:116–126, 1972

    Google Scholar 

  9. Soloway RD, Carlson HC, Shoenfield LJ: A balloon-occludable T-tube for cholangiography and quantitative collection and reinfusion of bile in man. J Lab Clin Med 79:500–504, 1972

    Google Scholar 

  10. Committee on Dietetics of the Mayo Clinic: Mayo Clinic Diet Manual 1971, 4th ed. Phildelphia, WB Saunders Co

    Google Scholar 

  11. Heirwegh KPM, Fevery J, Meuwissen JATP, DeGroote J: Recent advances in the separation and analysis of diazopositive bile pigments. Methods Biochem Anal 22:205–250, 1974

    Google Scholar 

  12. Trotman BW, Roy-Chowdhury J, Wirt GD, Bernstein SE: Azodipyrroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide. Anal Biochem 121:175–180, 1982

    Google Scholar 

  13. Ostrow JD, Murphy NH: Isolation and properties of conjugated bilirubin from bile. Biochem J 120:311–327, 1970

    Google Scholar 

  14. Fevery J, Verwilghen R, Tan TG, DeGroote J: Glucuronidation of bilirubin and the occurrence of pigment gallstones in patients with chronic hemolytic diseases. Eur J Clin Invest 10:219–226, 1980

    Google Scholar 

  15. Talalay P: Enzymatic analysis of steroid hormones. Methods Biochem Anal 8:119–143, 1960

    Google Scholar 

  16. Fiske CH, Subbarrow Y: the colorimetric determination of phosphorus. J Biol Chem 66:375–400, 1925

    Google Scholar 

  17. Abell LL, Levy BB, Brodie BB, Kendall FE: A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195:357–366, 1952

    Google Scholar 

  18. Trotman BW, Morris TA III, Sanchez HM, Soloway RD, Ostrow JD: Pigment versus cholesterol cholelithiasis: identification and quantification by infrared spectroscopy. Gastroenterology 72:495–498, 1977

    Google Scholar 

  19. Siskos PA, Cahill PT, Javitt NB: Serum bile acid analysis: A rapid direct enzymatic method using dual-beam spectrophotofluorimetry. J Lipid Res 18:666–671, 1977

    Google Scholar 

  20. Michaelsson M: Bilirubin determinations in serum and urine. Scand J Clin Lab Invest Suppl 56:40–50, 1961

    Google Scholar 

  21. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM: A new and rapid colorometric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95, 1961

    Google Scholar 

  22. Schmidt E: Glutamate dehydrogenase, UV assay.In Methods of Enzymatic Analysis. HU Bergmeyer (ed). New York, Academic Press, 1974 pp 650–656

    Google Scholar 

  23. Schmidt E: Strategy and evaluation of enzyme determinations in serum in disease of the liver and the biliary system.In Evaluation of Liver Function. LM Demers, LM Shaw (eds). Baltimore, Urban and Schwarzenberg 1978, pp 79–101

    Google Scholar 

  24. Orcutt J, Kozak P, Gillman S, Cummins LH: Micro-scale method for theophylline in body fluids by reverse-phase, high pressure liquid chromatography. Clin Chem 23:599–601, 1977

    Google Scholar 

  25. Black M, Billing BH, Heirwegh KPM: Determination of bilirubin UDP-glucuronyl transferase activity in needle biopsy specimens of human liver. Clin Chim Acta 29:27–35, 1970

    Google Scholar 

  26. Croxton E: Elementary Statistics: With Applications in Medicine and Biological Sciences. New York, Dover Publications, 1959, pp 1–376

    Google Scholar 

  27. Roy-Chowdhury J, Roy-Chowdhury N, Wu G, Shouval R, Arias IM: Bilirubin mono- and diglucuronide formation by human liverin vitro: Assay by high-pressure liquid chromatography. Hepatology 1:622–627, 1981

    Google Scholar 

  28. Rundle FF, Cass MH, Robson B, Middleton M: Biliary drainage after choledochostomy in man, with some observation on biliary fistula. Surgery 37:903–910, 1955

    Google Scholar 

  29. Soloway RD, Schoenfield LJ: Effects of meals and interruption of enterohepatic circulation on flow lipid composition, and cholesterol saturation in man after cholecystectomy. Am J Dig Dis 20:99–109, 1975

    Google Scholar 

  30. Goresky CA, Gordon ER, Shaffer EA, Pare P, Carassavas D, Aronoff A: Definition of a conjugation dysfunction in Gilbert's syndrome: Studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile. Clin Sci Mol Med 55:63–71, 1978

    Google Scholar 

  31. Black M, Sherlock S: Treatment of Gilbert's syndrome with phenobarbitone. Lancet 1:1359–1361, 1970

    Google Scholar 

  32. DeBarros SG, Balistreri WF, Soloway RD, Weiss SG, Miller PC, Soper K: Response of total and individual serum bile acids to endogenous and exogenous bile acid input into the enterohepatic circulation. Gastroenterology 82:647–652, 1982

    Google Scholar 

  33. Barrett PVD: Effects of caloric and noncaloric materials in fasting hyperbilirubinemia. Gastroenterology 68:361–369, 1975

    Google Scholar 

  34. Fevery J, Blanckaert N, Heirwegh KPM, Preaux A-M, Berthelot P: Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 60:970–979, 1977

    Google Scholar 

  35. Fevery J, Van Damme B, Michiels R, DeGroote J, Heirwegh KPM: Bilirubin conjugates in bile of man and rat in the normal state and in liver disease. J Clin Invest 51:2482–2492, 1972

    Google Scholar 

  36. Blitzer BL, Boyer JL: Cellular mechanisms of bile formation. Gastroenterology 82:346–357, 1982

    Google Scholar 

  37. Desmond PV, Patwardhan RV, Johnson RF, Schenker S: Impaired elimination of caffeine in cirrhosis. Dig Dis Sci 25:193–197, 1980

    Google Scholar 

  38. Parsons WD, Neims AH: Effect of smoking on caffeine clearance. Clin Pharmacol Ther 24:40–45, 1978

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trotman, B.W., Shaw, L., Roy-Chowdhury, J. et al. Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis. Digest Dis Sci 28, 753–762 (1983). https://doi.org/10.1007/BF01312568

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01312568

Keywords

Navigation